Symrise AG · XETR:SY1

Symrise — Investor Presentation (January 2020)

20 slides from Symrise's investor presentation, January 2020

  1. Slide 1: Symrise AG Investor Presentation

    Slide 1: Symrise AG Investor Presentation

    DISCLAIMER: ”The following document contains protected and confidential information from Symrise and must be kept in confidence. This information may not be used by anyone who obtains it if Symrise has not granted written permission to do so.” Symrise AG Investor Presentation Olaf Klinger (CFO) – Ja

  2. Slide 2: Symrise Overview

    Slide 2: Symrise Overview

    Symrise Overview Based on Symrise’s products provide exciting flavor and Sales: € 3.2bn* ~10,000 fragrance experiences and contribute to the health and well-being of consumers in EBITDA-margin: 20 %* mostly natural raw materials ~160 countries around including vanilla, citrus products, onions, fish,

  3. Slide 3: Our Industry: An attractive niche

    Slide 3: Our Industry: An attractive niche

    Our Industry An attractive niche Megatrends support organic growth: Industry tied to population growth and …health & wellness … middle class boom & urbanization … naturalness & disposable income; little dependence on cyclical, sustainability … traceability … vegetarian/vegan/halal/kosher food … econ

  4. Slide 4: Our Global Footprint

    Slide 4: Our Global Footprint

    Our Global Footprint >100 sites around the World 4

  5. Slide 5: Our Organizational Structure

    Slide 5: Our Organizational Structure

    Our Organizational Structure We operate our business through three segments Sales development In €m FLAVOR NUTRITION SCENT & CARE Flavor Diana Fragrances Cosmetic Ingredients Aroma Molecules Beverages Food Fine fragrances Cosmetic actives Scent componentsMargin Savory Pet food Consumer fragrances EB

  6. Slide 6: Our Corporate Strategy

    Slide 6: Our Corporate Strategy

    Our Corporate strategy Consequent strategy implementation pays off Vision Vision Strategic priorities Growth Growth Efficiency Portfolio Focus on organic growth by implementation · Growth in Emerging · Specific efficiency · Portfolio expansion in of incremental growth projects and capacity Markets p

  7. Slide 7: Driving growth through targeted investments

    Slide 7: Driving growth through targeted investments

    Driving growth through targeted investments … especially in R&D, technology and capacity expansion Selected growth initiatives 2018 Pet Food Pet Food Fragrances Cosmetic Ingredients and capacity expansion Elven/France Cervera/Spain Shanghai/China Charleston/USA In €m Production. €10m Production. €7m

  8. Slide 8: Carefully selected acquisitions like ADF/IDF

    Slide 8: Carefully selected acquisitions like ADF/IDF

    … and carefully selected acquisitions like ADF/IDF A unique provider of meat- and egg-based protein ADF/IDF • is operating 2 business segments… … serving a diversified client base Key multinationals $136m Long-standing relationship Chicken 62 % Recurring and stable revenue $84m Egg 38 % Growing regi

  9. Slide 9: Backward integration

    Slide 9: Backward integration

    Backward integration Serving the trend towards naturals & traceability 1. Strategic acquisitions that enable Industry-leading backward integration us to move closer to the origin of the raw 4. Long-term contracts and materials we process. sustainability partnerships with Naturals and synthetics, e.g

  10. Slide 10: Well-balanced Business Portfolio

    Slide 10: Well-balanced Business Portfolio

    Well-balanced Business Portfolio across segments, customers, regions and markets Symrise’s 12 largest customers Sales distribution by Segment Sales distribution by Region Distribution by division / BU Latin Nutrition America Flavor Diana Food Diana Pet Fragnance Oral Care Cosmetic Aroma Food Ingredi

  11. Slide 11: Expansion beyond traditional Flavor & Fragrances

    Slide 11: Expansion beyond traditional Flavor & Fragrances

    Expansion beyond traditional Flavor & Fragrances A unique portfolio with new growth areas Our portfolio today Leading positions in key application areas Scent Flavors — — Perfumes Nr.1 Nr.1 Natural vanilla Oral care Savory Personal care Beverages Home care Nr.1 Sweet Fragrance ingredients Care Nutri

  12. Slide 12: Financial Performance: Profitable growth since IPO

    Slide 12: Financial Performance: Profitable growth since IPO

    Financial Performance Profitable growth since IPO EBITDA Development of Sales / EBITDA margin-target Sales and EBITDA in €m, margin in % since 2012 22% EBITDA margin Ľ 19.8 21.3 19.9 18.0 21.1 20.0 19.5 20.4 21.9 22.0 21.5 21.0 20.0 19% CAGR 06-18 8.2 % Sales 1,229 1,275 1,320 1,362 1,572 1,584 1,73

  13. Slide 13: Financial Highlights H1 2019

    Slide 13: Financial Highlights H1 2019

    Financial Highlights H1 2019 Continued strong performance Sales Business Free Net debt / EBITDA(N)1 Cash Flow € 1,692m +7.4% 7.8% 1.8x +6.2% vs. 7.3 % H1 2018 Incl. provisions for Organic growth in Reporting pensions 2.7x currency EBITDA(N)1 margin Net income¹ Outlook 2019: Improved EBITDA(N)1 margi

  14. Slide 14: 9M 2019: On track for strong growth

    Slide 14: 9M 2019: On track for strong growth

    9M 2019 On track for strong growth Symrise Group Sales by Region in € million Sales in € million (Organic growth in %) 5.8% 1.2% 7.1% 312.0 +10.7% 29.1 1,086.9 139.2 +4.6% 567.6 2,550.9 +7.5% 2,382.6 EAME 584.4 Northern America +3.9% Asia/Pacific 9M 2018 Organic growth Portfolio FX 9M 2019 Latin Ame

  15. Slide 15: Operational Highlights H1 / 9M

    Slide 15: Operational Highlights H1 / 9M

    Operational Highlights H1 / 9M Strategy execution to achieve objectives 2019 Growth Efficiency Portfolio Menthol: new plant in the US plant Cosmetic Ingredients: opening of Acquisition ADF/IDF: — new development center in Holzminden US-based provider of natural protein Flavor: opening of liquid plan

  16. Slide 16: Investment Highlights

    Slide 16: Investment Highlights

    Investment Highlights Diversified, stable and profitable growth Broadest product portfolio in the industry Highest growth rates in the industry, …pet food… probiotics… cosmetics… flavors … fragrances… aroma further expansion in adjacent areas molecules … aqua … Leading supplier of consumer ingredien

  17. Slide 17: Outlook specified for 2019

    Slide 17: Outlook specified for 2019

    Outlook specified for 2019 Normalized EBITDA margin of around 21 % Targets 2019 Growth dynamics — Organic growth Strategically well-positioned, sustainable growth opportunities through differentiated portfolio 5-7% — Added competencies through integration of ADF/IDF CAGR — Industry-leading backward

  18. Slide 18: Objectives 2025

    Slide 18: Objectives 2025

    Objectives 2025 supported by our proven strategy Financial goals until 2020 until 2025 Sales growth 5 – 7 % pa (CAGR) 5 – 7 % pa (CAGR) Sales in Emerging Markets > 50 % > 50 % Customer mix 1/3 global, regional, local 1/3 global, regional, local EBITDA margin 19 – 22 % 20 – 23 % due to more favorable

  19. Slide 19: Long-term growth objective confirmed

    Slide 19: Long-term growth objective confirmed

    Long-term growth objective confirmed Doubling sales by 2025 Long-term objectives 2025 Efficient set up, global In € bn presence and strong portfolio support business performance in mid-term until 2022 as well as in long-term 2025 € 5.5 – 6.0 bn € 4.0 – 4.5 bn € 3.0 bn Organic growth € 1.3 bn Increme

  20. Slide 20: Financial calendar & contact

    Slide 20: Financial calendar & contact

    Symrise AG Financial calendar & contact Financial Calendar Contact March 11, 2020 Symrise AG Full Year Results 2019, Frankfurt Investor Relations Muehlenfeldstrasse 1 April 28, 2020 37603 Holzminden, Germany 3M 2020 trading statement Tobias Erfurth August 6, 2020 tobias.erfurth@symrise.com 6M 2020 r

Source: Internet Archive copy of symrise.com

More decks from Symrise AG

All 71 Symrise decks